用于治疗儿科失眠的药物
Vijayabharathi Ekambaram1, Judith Owens2
1Department of Psychiatry, University of Central Florida, HCA Florida Healthcare Program, 8383 N. Davis Hwy, Pensacola, FL 32514, USA.
The Psychiatric clinics of North America
|February 1, 2024
概括
儿科失眠会对儿童的健康和发育产生负面影响. 这篇评论审查了FDA批准的,非处方药和非标签药物用于儿科失眠,强调与行为治疗的结合,以获得持久的结果.
科学领域:
- 儿科睡眠医学 儿科睡眠医学
- 药理学 药理学是指药理学的学科.
- 儿童心理学 儿童心理学
背景情况:
- 儿科失眠对儿童的身体,精神,认知和社会福祉构成重大风险,降低生活质量.
- 目前,没有药物被食品和药物管理局 (FDA) 专门批准用于治疗儿科失眠.
- 对于儿科失眠的现有药理疗法主要是基于成人数据或有限的病例报告.
研究的目的:
- 审查FDA批准的 (成人),非处方药和非标签药物治疗儿科失眠.
- 为临床医生提供一般原则,实践指南和药理学考虑,以便在儿科患者中选择药物.
- 强调将药理学管理与基于证据的行为疗法的整合的重要性.
主要方法:
- 对FDA批准的药物 (成人适用药物),非处方睡眠辅助药物和在儿科失眠中常用的非标签药物的综合文献综述.
- 分析现有的实践指南和临床数据,涉及儿科失眠的药理管理.
- 综合信息,以指导临床决策,为儿童的药物选择.
主要成果:
- 该审查对可用的药理选择进行了分类,包括批准用于成人失眠的处方药,随时可用的非处方药和用于儿科患者的非标签治疗.
- 它概述了临床医生关于药物选择,剂量,潜在副作用和儿童监测的关键考虑因素.
- 证据支持行为疗法的辅助作用,以实现儿童失眠的持续改善.
结论:
- 儿科失眠的药理管理需要仔细考虑现有证据,主要来自成人研究和病例报告,由于缺乏FDA批准的儿科治疗方法.
- 临床医生应该将药理学策略与行为疗法相结合,这些行为疗法为儿科失眠提供了经过证明的长期结果.
- 本综述为医疗保健提供者提供指南,以优化儿科患者药物选择和管理.
相关概念视频
01:19Management of Insomnia
250
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
250
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
176
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
176
01:23Sedatives and Hypnotics: Overview
382
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
382
01:14CNS Depressants: Barbiturates and Benzodiazepines
267
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
267
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
251
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
251
01:20Sedatives and Hypnotics Drugs: Barbiturates
281
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
281